Kelly is a life sciences strategist with over 20 years of commercial and technical experience marketing to drug discovery, development, and QC. Her expertise spans go-to-market strategy, brand development, and market intelligence across bio/pharma technology and service providers. Kelly was elected to the ISPE Boston Chapter’s Board of Directors in 2025 and has been an active ISPE member and volunteer, organizing and moderating numerous virtual and in-person events. At Procegence, she advises leadership on strategic focus, brand refinement, and go-to-market alignment.